5 C) in obese OA patients (median 6.12%, range 0.84–21.9%) were increased compared with non-obese OA patients (median 0.882%, range 0.54–1.77%); however, this did not quite reach significance.
← all excerpts
Expansion of myeloid-derived suppressor cells contributes to metabolic osteoarthritis through subchondral bone remodeling.
1
—
—